Solution NMR studies of amphibian antimicrobial peptides: Linking structure to function?  by Haney, Evan F. et al.
Biochimica et Biophysica Acta 1788 (2009) 1639–1655
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemReview
Solution NMR studies of amphibian antimicrobial peptides: Linking structure
to function?
Evan F. Haney a, Howard N. Hunter a,1, Katsumi Matsuzaki b, Hans J. Vogel a,⁎
a Structural Biology Research Group, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada T2N 1N4
b Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501 Japan⁎ Corresponding author. Tel.: +1 403 220 6006; fax:
E-mail address: vogel@ucalgary.ca (H.J. Vogel).
1 Current address: Department of Chemistry, York Un
0005-2736/$ – see front matter © 2009 Elsevier B.V. A
doi:10.1016/j.bbamem.2009.01.002a b s t r a c ta r t i c l e i n f oArticle history: The high-resolution three-
Received 20 October 2008
Received in revised form 19 December 2008
Accepted 9 January 2009
Available online 15 January 2009
Keywords:
Amphibian antimicrobial peptide
Nuclear magnetic resonance
Solution structure
Peptide–membrane interaction
Antimicrobial peptide synergydimensional structure of an antimicrobial peptide has implications for the
mechanism of its antimicrobial activity, as the conformation of the peptide provides insights into the
intermolecular interactions that govern the binding to its biological target. For many cationic antimicrobial
peptides the negatively charged membranes surrounding the bacterial cell appear to be a main target. In
contrast to what has been found for other classes of antimicrobial peptides, solution NMR studies have
revealed that in spite of the wide diversity in the amino acid sequences of amphibian antimicrobial peptides
(AAMPs), they all adopt amphipathic α-helical structures in the presence of membrane-mimetic micelles,
bicelles or organic solvent mixtures. In some cases the amphipathic AAMP structures are directly membrane-
perturbing (e.g. magainin, aurein and the rana-box peptides), in other instances the peptide spontaneously
passes through the membrane and acts on intracellular targets (e.g. buforin). Armed with a high-resolution
structure, it is possible to relate the peptide structure to other relevant biophysical and biological data to
elucidate a mechanism of action. While many linear AAMPs have signiﬁcant antimicrobial activity of their
own, mixtures of peptides sometimes have vastly improved antibiotic effects. Thus, synergy among
antimicrobial peptides is an avenue of research that has recently attracted considerable attention. While
synergistic relationships between AAMPs are well described, it is becoming increasingly evident that
analyzing the intermolecular interactions between these peptides will be essential for understanding the
increased antimicrobial effect. NMR structure determination of hybrid peptides composed of known
antimicrobial peptides can shed light on these intricate synergistic relationships. In this work, we present the
ﬁrst NMR solution structure of a hybrid peptide composed of magainin 2 and PGLa bound to SDS and DPC
micelles. The hybrid peptide adopts a largely helical conformation and some information regarding the inter-
helix organization of this molecule is reported. The solution structure of the micelle associated MG2–PGLa
hybrid peptide highlights the importance of examining structural contributions to the synergistic
relationships but it also demonstrates the limitations in the resolution of the currently used solution NMR
techniques for probing such interactions. Future studies of antimicrobial peptide synergy will likely require
stable isotope-labeling strategies, similar to those used in NMR studies of proteins.
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Amphibian skin has proven to be a valuable source of anti-
microbial peptides. A quick search in the antimicrobial peptide
database reveals almost 400 peptides that have been isolated from
frogs [1]. With their obvious potential as novel therapeutic agents,
understanding the molecular mechanisms that underlies their mode
of action is essential for developing peptide based antibiotics. While
there are several biophysical techniques that can provide useful
information regarding the interactions between antimicrobial pep-
tides and their biological targets, examining the solution structure of
the peptide remains one of the most important pieces of information
when studying this class of peptides. The three dimensional
structure identiﬁes where each residue resides and highlights
those that are important for activity or those that could potentially
be mutated to increase antimicrobial activity.
The common theme in examining the solution structures of
amphibious antimicrobial peptides, as is the case with most other
antimicrobial peptides, is that these peptides are unstructured in
aqueous solution and that they typically only adopt a well-deﬁned
structure when they interact with the bacterial membrane. Often the
mechanism of action of antimicrobial peptides is predicated on this
interaction with the membrane and once the peptide binds it can
affect the stability and integrity of themembrane leading to cell death.
Alternatively, the membrane interaction is a transient effect as the
peptide passes through the phospholipid bilayer to interact with
intracellular targets. These non-speciﬁc mechanisms of action range
from the formation of pores to the complete solubilization and
disintegration of the membrane and they have been summarized in
numerous review articles [2–4]. Knowing how a peptide folds and
interacts with lipids or target molecules allows us to link many of the
other biophysical measurements to the antimicrobial activity and also
allows for the identiﬁcation of key residues that are essential for the
antimicrobial activity.
The two techniques that can be used for structure determina-
tion are X-ray crystallography and NMR spectroscopy. NMR has
been the most widely employed tool in this area of research,
mostly because peptide–lipid complexes cannot be crystallized.
Moreover, the relatively short size of these peptides makes them
attractive objects for analysis by NMR spectroscopy [5]. Unfortu-
nately, however, bacterial cells or even phospholipid vesicles,
among other limitations, are too large for conventional NMR
spectroscopy techniques so alternatives have been developed to
examine the structure of these peptides in a membrane mimetic
environment. To date, by far the most commonly used solvent for
determining the solution structure of amphibian antimicrobial
peptides (AAMPs) is a mixture of deuterated triﬂuoroethanol
(TFE) and water. This solvent can induce the formation of α-
helical secondary structure [6] and it is assumed that the aqueous
TFE-induced conformation is similar to the one that would be
observed in a biological membrane. Oftentimes, circular dichroism
spectroscopy is used to conﬁrm that the conformation of the
peptide in TFE is indeed similar to that of the peptide bound to
membrane-mimetic micelles or vesicles as in the case of aurein [7],
nigrocin [8] and gaegurin 4 [9]. The CD experiments allow
researchers to link the TFE solution NMR structure to a more
realistic membrane environment.Deuterated detergent micelles are also commonly used in
structural studies of antimicrobial peptides [10–12] and are consi-
dered a better representation of the peptide structure bound to a
bacterial membrane. Sodium dodecylsulphate (SDS) and dodecylpho-
sphocholine (DPC) are the main detergent micelles used in NMR
spectroscopy. SDS molecules possess a negatively charged head group
which gives the surface of themicelle a net negative charge and serves
as a model for bacterial cell membranes which are also negatively
charged. DPC molecules, on the other hand, are zwitterionic and
confer no net charge to the surface of the micelle which makes them
similar to the outer leaﬂet of eukaryotic cell membranes. The
advantage of using detergent micelles is that they are better mimics
than TFE of a phospholipid bilayer due to the separation of the
hydrophobic acyl chains and the hydrophilic head groups but they are
still small enough to apply conventional proton NMR techniques
without signiﬁcantly broadening the signals of the peptide. Recently,
solution state NMR techniques have been used to examine the
structures of antimicrobial peptides bound to larger phospholipid
lipid vesicles [13], giving an even better representation of the peptide
conformation and potentially the same conformation as that found in
nature. While these techniques are promising, they are still limited by
the size of the complex formed by the peptide and the vesicle and the
strength of the interaction between the peptide and the surface of the
bilayer.
In this review, we will examine the NMR-derived solution
structures of various classes of AAMPs and discuss the implications
of these structural motifs for the antimicrobial activity of the peptides.
Additionally, we will expand on a relatively new concept in
antimicrobial peptide research, the idea of synergy between anti-
microbial peptides and the impact that combinations of peptides can
have on bacterial membranes; remarkably in some cases the activity is
dramatically increased compared to the individual peptides on their
own. Finally, we will present the previously unreported solution
structure of a hybrid peptide composed of the frog peptides, magainin
2 and PGLa, bound to SDS and DPC micelles with the goal of providing
novel insights into the molecular interactions that are responsible for
the observed synergistic antimicrobial activity.2. Solution structures of amphibian antimicrobial peptides
2.1. Magainin and related peptides
It is ﬁtting to start our discussion of solution structures of
antimicrobial peptides with magainin, the ﬁrst antimicrobial peptide
isolated from the skin of the African clawed frog Xenopus laevis [14].
Because it was one of the ﬁrst identiﬁed antimicrobial peptides,
there has been considerable research associated with its structure
and mechanism of action. Shortly after its discovery, the solution
structure of magainin 2 (GIGKFLHSAKKFGKAFVGEIMNS) was exam-
ined using NMR spectroscopy [15]. The solution structure of
magainin 2 was found to be solvent dependent as the peptide
produced poor chemical shift dispersion in the methyl region of the
spectrum in an aqueous environment, indicative of a random coil
structure. However, the addition of a small amount of perdeuterated
TFE to an aqueous solution of the peptide induced an α-helical
conformation in magainin 2, a conclusion based on the resulting
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TFE was revisited in more detail in 1997 when Gessel et al. [16]
examined the conformation of magainin in TFE as well as in the
presence of SDS and DPC micelles. Sequential and medium range
nOes, taken together with the CαH chemical shift index of magainin
2 revealed a remarkably similar conformation of the peptide in all of
the membrane mimetics. Based on these results, magainin 2 formed
an α-helix from residues 2 to 22 in the presence of both detergent
micelles while the helix in a TFE/water mixture was only slightly
shorter, spanning residues 3–22 [16]. Using simulated annealing,
restrained molecular dynamics and energy minimization, the
detailed structure of magainin 2 bound to DPC micelles was
calculated and determined to form a well-deﬁned helix across
residues 4–20 (Fig. 1). Additionally, the peptide was curved with a
kink centered around Phe12 and Gly13 while many of the
hydrophobic side chains were localized on the concave side of the
helix. The amphipathic helical structure of magainin is in agreement
with earlier solid state NMR experiments that demonstrated that the
helical axis of magainin 2 lies parallel to the surface of the
membrane [17,18] suggesting that the peptide sits at the lipid
water interface of the bilayer with the hydrophobic residues
anchoring the peptide to the acyl chains in the hydrophobic core.
A more recent study looked at the SDS- and DPC-bound conforma-
tion of (Ala8,13,18) magainin 2 as well as magainin 1 bound to DPC
micelles in an attempt to understand the non-covalent interactions
that drive the formation of the helix in the peptide in the presence of
detergent [19]. The synthetic (Ala8,13,18) magainin 2 peptide has high
antimicrobial activity but higher hydrophobicity and rigidity com-
pared to magainin 2. Both peptides formed helical structures in the
presence of micelles, however, the differences between the SDS and
DPC bound structures of (Ala8,13,18) magainin 2 were attributed to
net energy stabilization resulting from intramolecular contacts
between charged side chains of the peptide or increased energy
resulting from intermolecular contacts between hydrophobic resi-
dues inserting into the center of the micelle [19].
The formation of an amphipathic helix is now known to be a
common structural motif for the magainin family of peptides. For
instance PGLa (GMASKAGAIAGKIAKVALKAL) is a 21-residue member
of the magainin family of peptides and it has been shown to form a
helix in the presence of detergent micelles [20] and small unilamellar
vesicles [21]. Solid state 15N NMR of PGLa in oriented bilayers showedFig. 1. Solution structure of magainin 2 bound to DPC micelles (PDB ID 2MAG). A well
deﬁned helix is seen between residues 2–22 with an RMSD of 0.684 Å ﬁt across the
backbone atoms (A). The amphipathic nature of the helix is apparent when the side
chain distribution is analyzed (B). Hydrophobic amino acids are colored in shades of
green (Phe, Trp in green; Ile, Val,Leu in dark green; Ala in pale green), cationic residues
are indicated in blue and anionic residues are shown in red.that the helical axis of PGLa lies parallel to the surface of the
phospholipid membrane and suggests that the interactions between
the peptide and a phospholipid bilayer are similar to that of magainin
2 [20]. Furthermore, two synthetic variants of magainin, MSI-78 and
MSI-594, also formed helical structures in the presence of DPC
micelles. Of particular interest in this case is that MSI-78 forms an
antiparallel dimer through numerous hydrophobic interactions
between the hydrophobic faces of the amphipathic helices. Con-
versely, the MSI-594 variant is monomeric under the same conditions,
a structural difference that results from the differing amino acid
composition at the C-terminus [22].
Evidently, the solution structures of membrane-bound magainin
peptides are all α-helical and based on other experimental data, the
helical axis of the peptide lies parallel to the surface of the bilayer. Of
particular interest to researchers is elucidating the mechanism
through which magainins exert their antimicrobial effect on bacteria.
The similarity between the published structures strongly suggests
similar modes of action for all the magainin peptides. However, the
dimerization observed in the case of MSI-78 is not a unique
observation for magainin based peptides and increasing evidence
suggests that the mechanism of action of this family of peptides
actually involves more complex oligomerization with the binding of
the peptide to the membrane representing only the ﬁrst step of many
that are necessary for antimicrobial activity. This concept will be
discussed in more depth later in this review when we examine the
idea of synergy between AAMPs.2.2. Caerins
Caerins are a class of antimicrobial peptides found in the skin
secretions of the Australian green tree frog [23,24]. Caerin 1.1 is a 25-
residue peptide and is the major caerin peptide found in Litoria
splendida [25]. Helical wheel projections reveal an amphipathic
structure for this peptide which suggests a similar membrane
interaction mechanism to the magainin peptides described above.
However, the solution structure of caerin 1.1 determined in triﬂuoro-
ethanol/water (50:50) revealed a unique structural feature of this
peptide which is signiﬁcantly different from magainin. Two proline
residues in the sequence of caerin 1.1 (GLLSVLGSVAKHVLPHVVP-
VIAEHL) induce a distinct bend leading to two well deﬁned helical
regions stretching from Leu2 to Lys 11 and Val 17 to His24 [25]. This
helix–bend–helix conformation is still amphipathic as the concave
portion of the peptide harborsmanyof the hydrophobic residueswhile
the charged residues Lys, His and Glu are positioned on the opposite
face. More recent NMR structural studies in DPC micelles reveal that
the helix–bend–helix conformation of caerin 1.1 is retained in the
presence of DPC micelles [26]. Caerin 1.4, a related peptide that only
differs by two amino acids from caerin 1.1 (V5S and G7S), was also
found to adopt this helix–bend–helix motif in TFE/water and in
DPC micelles [26].
These two proline residues, Pro15 and Pro19, are conserved in all
caerin 1 peptides [27–30] and may play a role in the mechanism of
antimicrobial action. To further examine their importance, mutations
to caerin 1.1 were made where one or both prolines were substituted
with a Gly resulting in peptides with reduced antimicrobial activity
[25]. These activity results were ﬁrst published in 1997, in
conjunction with the solution structure of caerin 1.1 in 50% TFE,
and at the time it was postulated that the Gly residues would offer
increased ﬂexibility to the peptide backbone and disrupt the
preferred orientation between the two helices, or alternatively,
disrupt the stability of the C-terminal helix because Gly residues at
the termini of helices can be disruptive to their stability [25].
Mutating the Pro residues to Ala also resulted in signiﬁcantly lower
antimicrobial activity against a variety of bacterial species [26]
further suggesting that the two prolines offered an essential
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were reported for these mutant peptides.
In 2004, Pukala et al. [30] sought to describe more precisely the
importance of this ﬂexible hinge in caerin 1.1 and they determined
the solution structures of Gly15Gly19-Caerin 1.1 in 50% TFE and
Ala15Ala19-Caerin 1.1 in the presence of 95% TFE. The double Gly
mutant had both an N-terminal and C-terminal helix separated by a
region of conformational ﬂexibility centered on Gly15. However, the
ﬂexibility in the Gly15/Gly19 peptide was not as pronounced as that
seen in caerin 1.1. The double Ala mutant of caerin 1.1 formed a well
deﬁned helix across the entire peptide and the ﬂexibility at position
15 was essentially lost, giving this mutant a much more rigid
structure compared to caerin 1.1 (Fig. 2). These structural results,
coupled with the decreased biological activity observed in the
double Gly and double Ala mutants of caerin 1, indicate that the
ﬂexible hinge around Pro15 must allow for an optimal orientation
between the N- and C-terminal alpha helices when the peptide
interacts with bacterial cell membranes [30].
Maculatin 1.1 (GLFGVLAKVAAHVVPAIAEHF) is an antimicrobial
peptide isolated from Litoria genimacula that is similar to caerin in
its primary sequence except that four amino acids in the middle of
the peptide are missing [31]. This 21 residue peptide adopts an α-
helix in TFE/water and in the presence of DPC micelles but it has a
Pro residue at position 15 which causes a slight kink in the helix [32]
Interestingly, mutating this Pro residue to an Ala reduces the
antimicrobial activity 5- to 10-fold and simultaneously removes the
kink that is found in the parent peptide [32]. Thus, like the caerinFig. 3. Solution structure of aurein 1.2 bound to SDS micelles (PDB ID 1VM5). The
peptide forms a well deﬁned helix across all of the 13 residues of the peptide and the
hydrophobic residues (in green) are opposite the cationic (blue) and anionic (red)
residues (A) making this peptide highly amphipathic. The highly amphipathic nature of
this peptide is evident when examining the surface charge distribution. When looking
directly at the hydrophobic surface (B) there are no charged residues found in this
region (white denotes uncharged surface). On the opposite side (C) the charged
residues appear (red, negative; blue, positive). Of particular interest in the case of
Aurein 1.2 is that the length of the helix is only ∼20 Å, making it too short to span the
width of a normal bilayer (see text).
Fig. 2. Solution structures of caerin 1 peptides indicating the structural differences
between caerin 1.1 (A) and Gly15Gly19-Caerin 1.1 (B) and Ala15Ala19-Caerin 1.1 (C).
The same coloring scheme used to color the magainin residues has been used here.peptides, the single proline residue maintains the conformation of
maculatin in a speciﬁc position that favors the interaction with
bacterial membranes.
The argument that the Pro residues offer a special structural
element to the caerin peptides becomes even more compelling when
we examine the solution structure of caerin 4.1 (GLWQKIKSAAG-
DLASGIEVGIKS), which is produced by Litoria caerulea. It differs from
the caerin 1 peptides because it lacks the bend-inducing proline
residues. Caerin 4.1 is also unique because it displays selective activity
against Pasteurella haemolytica,Micrococcus luteus and Escherichia coli
[26,33] while caerin 1.1 and maculatin 1.1 have broad spectrum
activity against a variety of bacterial species [23,25,31]. As expected,
caerin 4.1 forms a well deﬁned amphipathic helix in TFE/water but
with signiﬁcantly reduced ﬂexibility in the backbone of the peptide
compared to the structures reported for caerin 1.1 [33]. It is postulated
that the more rigid helix in caerin 4.1 does not allow it to adapt to
various bacterial membranes, while the ﬂexible caerin 1.1 can interact
more efﬁciently with membranes of different composition and
topology, which explains the difference between the antimicrobial
activities of these two peptides [33].
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While numerous new antimicrobial peptides are still being
discovered in the skin secretions of amphibian organisms, many
have a high helix-forming propensity and predict that they will form
linear amphipathicα-helices. For example, citropin 1.1 [34], uperin 3.6
[35], hylaseptin P1 [36] and frenatin 1 [37] all adopt amphipathic α-
helical conformations in the presence of TFE. These structural data
suggest that these peptides intercalate into bilayers at the lipid/water
interface and it is thought that these peptides act through one of
several mechanisms of antimicrobial activity that have been described
for linear amphipathic helical peptides [2,4]. The fact that the
amphipathic α-helix is such a prominent structural motif for AAMPs
is intriguing because many other classes of antimicrobial peptides
exist in β-sheet or well-deﬁned turn like structures. For example
lactoferricin [38], tachyplesin I [39] and protegrin [40] adopt β-sheet
conformations, while tritrpticin [41] and indolicidin [42] have a two-
turn structure.
There are several other examples of related AAMPs that provide
interesting insights into helical antimicrobial peptide conformations.
For instance, aureins are relatively short antimicrobial peptides (13–25
residues) isolated from Litoria aurea and Litoria raniformis that
possess antibacterial and anticancer activity [43]. Various NMR
solutions structures have been reported for these related peptides.
The ﬁrst solution structure for one of the shorter 13-residue peptides,
aurein 1.2 (GLFDIIKKIAESF), revealed a well deﬁned α-helix in 70%
d3-TFE with distinct hydrophobic and hydrophilic faces [43]. In the
presence of SDS micelles, aurein 1.2 also forms a well deﬁned
amphipathic α-helix with a large hydrophobic surface [44] (Fig. 3).
While the solution structures obtained in membrane mimetics
suggest that aurein 1.2 interacts with bacterial cell membranes, the
short length of the peptide (∼20 Å) would preclude it from adopting
a transmembrane orientation, since solution X-ray scattering has
shown the average bilayer thickness of E. colimembranes to be 37.5 Å
[45]. 31P NMR results of vesicles composed of 25% dioleoyl
phosphatidylglycerol and 75% dioleoyl phosphatidylethanolamine in
the presence of aurein 1.2 showed that this peptide actually
destabilizes the bilayer structure by inducing non-lamellar lipid
phases [44] which is responsible for membrane destabilization and
cell death. The solution structures of two 16 residue peptides, aurein
2.2 and 2.3, were also found to be helical in 25% d3-TFE whileTable 1
Percentage of helical structure in amphibian antimicrobial peptides predicted by AGADIR [1
Peptide Sequence
Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS
PGLa GMASKAGAIAGKIAKVALKAL-NH2
Caerin 1.1 GLLSVLGSVAKHVLPHVVPVIAEHL-NH2
Gly15Gly19-Caerin 1.1 GLLSVLGSVAKHVLGHVVGVIAEHL-NH2
Ala15Ala19-Caerin 1.1 GLLSVLGSVAKHVLAHVVAVIAEHL-NH2
Caerin 1.4 GLLSSLSSVAKHVLPHVVPVIAEHL-NH2
Caerin 4.1 GLWQKIKSAAGDLASGIVEGIKS-NH2
Maculatin 1.1 GLFGVLAKVAAHVVPAIAEHF-NH2
Citropin 1.1 GLFDVIKKVASVIGGL-NH2
Uperin 3.6 GVIDAAKKVVNVLKNLF-NH2
Hylaseptin P1 GILDAIKAIAKAAG
Frenatin 3 GLMSVLGHAVGNVLGGLFKPKS
Aurein 1.2 GLFDIIKKIAESF-NH2
Aurein 2.2 GLFDIVKKVVGALGSL-NH2
Aurein 2.3 GLFDIVKKVVGAIGSL-NH2
Dermaseptin B2 GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV-NH2
Dermaseptin S9 GLRSKIWLWVLLMIWQESNKFKKM
Temporin A FLPLIGRVLSGIL-NH2
Temporin L FVQWFSKLGRIL-NH2
Buforin II TRSSRAGLQFPVGRVHRLLRK
All of these peptides are unstructured in aqueous solution but adopt helical structures in the
input parameter for the AGADIR server so in cases where the amidated peptide was examinoriented CD experiments in the presence of DMPC or a 1:1 mixture of
DMPC:DMPG indicated that the peptides were surface oriented at low
concentrations but inserted themselves into the bilayer as the
concentration increased [7]. The published solution structures of
the aurein family of peptides clearly demonstrate the importance of
the amphipathic α-helix for the antimicrobial activity.
The dermaseptins are a large family of antimicrobial peptides
produced by the South American hylid frogs. These cationic peptides,
ranging between 24 and 34 residues in length, display broad spectrum
antibacterial activity against Gram-positive, Gram-negative, yeast and
fungi while possessing limited hemolytic activity [46–49]. Various
helical structures have been reported for the dermaseptins including
dermaseptin B2 in TFE/water and SDS [50] and dermaseptin S9 in 30%
TFE [51]. Like many of the previous examples, dermaseptin B2 forms
amphipathic α-helical structures in the presence of TFE and SDS
although there are regions of the peptide with signiﬁcantly increased
ﬂexibility [50]. Conversely, the structure of dermaseptin S9 in 30% TFE
also forms a well deﬁned helix between residues 6 and 21 however,
this structure is unique because the helix is non-amphipathic and
instead adopts a tripartite structure with a central hydrophobic core
ﬂanked by hydrophilic regions at both termini [51].
Another dermaseptin, known as dermaseptin S3, also behaves
differently from most AAMPs in membrane mimetic solvent. NMR
structure analysis of dermaseptin S3 in 20% TFE revealed a largely
unstructured conformation and helical secondary structure only
emerged upon amidation of the C-terminus even though CD results
indicated that the peptide adopted predominantly helical conforma-
tions in 20% aqueous TFE [52]. While it is unclear if increasing the TFE
concentration would further induce helical structure in the native
peptide, the increase in activity observed for the carboxyamidated
peptide was attributed to increasing the overall positive charge of
the peptide and/or increasing helical content and the stability of the
amphipathic helix within the peptide. It could also be related to the
effect of the helix macro dipole, where the summed aligned dipoles
of the individual peptide bonds in a helix create a partial negative
charge at the C-terminal end of the helix and a partial positive at the
N-terminal end [53]. Removal of the negatively charged carboxylate
group by amidation would reduce the repulsion with the helix
macrodipole and could improve the helical stability at the C-
terminus. Acetylation of the N-terminus would have a similar effect
on the other end of the peptide.43–146], GOR4 [147,148] and HNN [148,149].
AGADIR % helix GOR4 % helix HNN % helix
0.33 17.39 39.13
2.80 47.62 80.95
0.28 0.00 12.00
0.46 20.00 44.00
1.05 40.00 84.00
0.33 16.00 40.00
0.89 34.78 60.87
1.00 33.33 80.95
1.33 0.00 68.75
2.39 35.29 82.35
5.22 35.71 78.57
0.18 0.00 45.45
9.99 30.77 69.23
1.03 0.00 62.50
0.82 0.00 18.75
9.79 63.64 81.82
31.78 63.64 81.82
0.28 0.00 53.85
0.68 0.00 58.33
0.51 0.00 38.10
presence of membrane mimetics (see text). The amidated C-terminus can be used as an
ed in the NMR study, it has been included in the secondary structure prediction.
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structures have been examined using solution NMR techniques.
Temporins were originally identiﬁed in the skin of the European red
frog Rana temporaria [54] and over 40 temporin sequences have now
been identiﬁed [55]. Temporins are among the shortest cationic
antimicrobial peptides found in nature (10–14 residues) but they still
display a wide range of antimicrobial activity against bacteria, viruses,
fungi, yeast and protozoa [55]. In an early study, the conformation of
temporin A (TA) in the presence of TFE/water (3:7) was determined
to be α-helical based on the chemical shift index of the alpha protons
[56]. However, the detailed solution structures of temporin A and L
(TL) were not published until recently when both peptides were
reported to form short amphipathic α-helices in the presence of SDS
and DPCmicelles [57]. It is also of note that TA and TL were found to be
surface oriented in the presence of SDS micelles but in the presence of
DPC, they preferred a perpendicular orientation compared to the
micelle surface with the N-terminus of the helix inserting into the
hydrophobic core of the micelle [57]. Temporins are known to interact
with the bacterial membrane but membrane perturbation is not the
lethal step in their activity [55,58]. The 13-residue helical structures of
TA and TL suggest potential oligomerization among temporins to
achieve their antimicrobial effect, an observation further supported by
the known synergy between temporin peptides [59].
Buforins represent an interesting example of α-helical antimicro-
bial peptide because they employ a unique mechanism of activity that
does not involve membrane perturbation. Buforin I and II were ﬁrst
isolated in the stomach of the Asian toad, Bufo bufo gargarizans, and
they display broad spectrum antimicrobial activity against bacteria
and fungi [60]. Buforin I is a 39-amino acid peptide with sequence
homology to the N-terminus of Xenopus histone H2A and buforin II is
a 21 amino acid fragment of buforin I. Both peptides are generated
from histone H2A through protease activity [60–62]. The solution
structure of buforin II in TFE/water is helical from residues 12 to 20
and 5 to 10 with both regions being separated by a hinge caused by a
Pro residue at position 11. The four N-terminal residues are relatively
unstructured [63]. Interestingly, Pro11 distorts the C-terminal helix in
such a way as to maximize the amphipathic nature of the C-terminal
helix [63]. This originally led researchers to postulate that buforin II
interacts with bacterial membranes in a similar fashion to other
amphibian peptides like the magainins. However, the exact mecha-
nism of activity of buforin II proved to be very different from the
membrane perturbing mechanisms proposed for most of the linear
amphipathic α-helices. Buforin II was found to kill E. coli cells without
lysing cell membranes, even at extremely high concentrations. This
activity was mediated by inhibition of cellular functions because
buforin II binds strongly to DNA and RNA [64]. A later study revealed
that the Pro residue that instigated the hinge in the structure of
buforin II was necessary for the cell-penetrating activity of buforin and
that mutating the proline residue led to buforin analogs that
aggregated on the cell surface and led to membrane destabilization
[65]. Additionally, N-terminal truncations of the two terminal residues
of buforin II slightly increased the antimicrobial activity of the peptide
while C-terminal deletions resulted in much lower activity [65]. All ofTable 2
Sequences and selected antimicrobial activities of macrocyclic antimicrobial peptides from
Peptide Sequence
Esculentin 1a GIFSKLAGKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC
Brevinin 2 GLLDSLKGFAATAGKGVLQSLLSTASCKLAKTC
Ranacyclin T GALRGCWTKSYPPKPCK-NH2
Ranalexin FLGGLIKIVPAMICAVTKKC
Gaegurin 4 GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLAKTC
Ranateurin-2CSa GLISSFKGVAKGVAKDLAGKLLETLKCKITGC
Nigrocin 2 GLLSKVLGVGKKVLCGVSGLC
Cys residues involved in a disulphide bridge are underlined and known helical sections fromthese results indicate that the length of the C-terminal helix and the
hinge induced by Pro11 are essential for cell permeability of buforin II
while the ﬂexible residues at the N-terminus are not as essential for
activity. It is interesting that buforin II adopts an amphipathic
α-helical conformation in a membrane mimetic but it does not
destabilize the membrane and instead translocates across the
membrane and interacts with intercellular targets. Other proline
rich antimicrobial peptides are known to act through non-lytic
mechanisms and in some cases their membrane translocation is
known to be mediated by the presence of speciﬁc membrane proteins
[66]. The case of buforin II can serve as a cautionary tale that solution
structures of antimicrobial peptides do not prove a speciﬁc mecha-
nism of action. The three-dimensional solution structures of anti-
microbial peptides must always be rationalized in the context of
relevant biophysical experiments in order to properly characterize the
mechanism of antimicrobial activity.
2.4. Unique amphibian peptide structures
By now it is obvious that most of the peptides are unfolded in
aqueous solution and that the most common secondary structure
motif of AAMPs is an α-helix; this structure only emerges when the
peptide is in the presence of detergent micelles or organic solvents
that promote the formation of secondary structure. Indeed, secondary
structure prediction of these peptides using the AGADIR program,
which is designed to predict the structure of linear peptides in
aqueous solution, reveals little or no secondary structure (Table 1).
However, when using other prediction programs that estimate the
presence of helices in globular proteins, signiﬁcant helicity is
predicted suggesting that many of these peptides have a high
propensity for helix formation, yet the helix requires stabilization by
an interacting surface such as the remainder of the protein or an
appropriate membrane surface. As such, predicting helical conforma-
tions for membrane bound amphibian peptides is difﬁcult as
evidenced by the range in values obtained using different on-line
tools (Table 1). Recently, interesting structures of unique AAMPs have
been reported and even though these peptides are largely α-helical in
their conformation, unique structural characteristics confer interes-
ting properties to these peptides that could have potential implica-
tions for their mechanisms of antimicrobial activity.
A class of structurally unique AAMPs contains an intermolecular
disulphide bridge in the C-terminal portion of the peptide that creates
a 7–9 residuemacrocyclic region in the peptide, sometimes referred to
as a “Rana box”. Many of these peptides originate from frogs in the
Rana genus and examples include esculentins [67], brevinins [68],
ranacyclins [69], ranalexins [70], gaegurins [71], ranateurins [72] and
nigrocins [8] (Table 2). One of the earliest reported structures for this
family of peptides was that of ranalexin. While unstructured in
aqueous solution, the presence of 30% TFE or DPC micelles causes
ranalexin to adopt anα-helical conformation stretching from residues
7 to 17 with the N-terminus remaining relatively unstructured. The
three residues at the C-terminus fold back onto the helix and are held
in place by the disulphide bond [73].the Rana genus.
Demonstrated antimicrobial activity against Ref
E. coli, B. megaterium, S. aureus [67]
B. subtilis, S. aureus, E. coli [68]
E. coli, Y. pseudotuberculosis, B. megaterium, S. lentus, M. luteus, C.
albicans, C. tropicalis, C. guiller-mondii
[69]
S. aureus, E. coli [70]
M. luteus, S. epidermis, B. subtilis, K. pneumonia, S. dysentariae [71]
E. coli, S. aureus [150]
M. luteus, S. dysenteriae, K. pneumoniae, S. typhimurium [8]
NMR solution structures are in bold. See text for structure references.
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demonstrates a predominantly α-helical structure with two amphi-
pathic helices (2–10 and 16–32) separated by a short loop region, 11–
15, that resembles a helix [9]. The structure of gaegurin 4 bound to SDS
micelles is remarkably similar with the N and C-terminal helices being
separated by a loop region that allows the two helices to orient
themselves at angles ranging from 60 to 120° [74]. In 80% deuterated
methanol, gaegurin 4 forms two amphipathic α-helices, one stretch-
ing from residues 2 to 23 and the other between residues 25 and 34
[75] (Fig. 4). The presence of a glycine residue at position 24 appears
to break the N-terminal helix of gaegurin 4 and it is proposed that the
N-terminal helix inserts into the hydrophobic core of the membrane
while the C-terminal portion, containing the Rana box, anchors
gaegurin 4 to the membrane surface. When the structure of the
reduced peptide was compared to the S–S cross-linked peptide, both
in TFE, it was found that they were essentially the same with only
some increased ﬂexibility at the C-terminus [9]. Interestingly, the
reduced form of gaegurin 4 displayed similar antimicrobial activity
compared to the native peptide suggesting that the mechanism of
antimicrobial activity of this peptide is independent of the conforma-
tion of the cyclic region of the peptide [9]. However, complete removal
of the Rana box results in a peptide that is only 3–5% as efﬁcient atFig. 4. Solution structure of gaegurin 4 in 80% deuterated methanol (PDB ID 2G9L). A
comparison between the backbone overlays of the ﬁrst 25 residues (A) and residues 27–
34 (B) highlights the conformational ﬂexibility offered by Gly26. Both of these regions
form amphipathic helices (Same residue coloring as used previously) and the C-
terminal disulphide bond (colored gold) appears to have no signiﬁcant effect on the
conformation of the peptide (C).forming ion channels but it does not affect the pore structure itself
[76]. This indicates that the Rana box is important for antimicrobial
activity but that the conformation is lipid dependent and, unexpec-
tedly, does not require the presence of an intact disulphide bond.
Ranateurin-2CSa is unstructured in an aqueous environment but
adopts a helix–turn–helix motif in the presence of 50% TFE [77].
Similar to the structures of ranalexin and gaegurin, the ﬁrst helix
extends from the N-terminus and encompasses residues 2–23 which
is disrupted by a Thr residue at position 24. A small helix forms
between residues 26–30 and the disulphide bond pulls this region
close the N-terminal helix which explains the turn structure observed
between residues 24 and 26 [77]. The solution structure of nigrocin, an
antimicrobial peptide isolated from Rana nigromaculata, also contains
a C-terminal disulphide linkage and forms awell deﬁned amphipathic
helix in TFE/water and in SDS across residues 4–17. Once again, the
C-terminal disulphide bond folds this region of the peptide back on
itself forming a cyclic structure at the C-terminus of the peptide [8].
Examples of antimicrobial peptides from Rana frogs with macrocylic
regions at the C-terminus are shown in Table 2.
The role of the disulphide bond of the Rana box peptides in relation
to their antimicrobial activity has so far remained elusive. For
example, the N-terminal fragment (1–18) of Esculentin-1, which
completely lacks the cyclic C-terminal segment, retains most of the
antimicrobial activity compared to the full length 46 residue peptide.
It is also less hemolytic than the larger peptide [78] suggesting that
the C-terminus may be responsible for a certain degree of cell
selectivity. Additionally, the C-terminal disulphide bridge may also be
responsible for determining how quickly the peptide acts upon
bacterial membranes as linearized esculentins act more slowly on P.
syringae and P.aeruginosa [79]. However, in other studies where the
antimicrobial activity of reduced and oxidized forms of these
macrocyclic peptides has been compared, very little difference in
activity is observed. As mentioned earlier, removing the disulphide
bond of gaegurin 4 does not greatly alter the antimicrobial activity of
the peptide nor does it signiﬁcantly alter the conformation [9]. Similar
results have been reported for ranalexin with the reduced and
oxidized peptides forming similar structures in TFE/water and both
peptides displaying similar antimicrobial activities [73]. Additionally
the antimicrobial activity of the reduced form of brevinin 1E is
identical to that of the disulphide bonded peptide, however removing
residues from the N-terminus greatly decreases the antimicrobial
activity [80]. Taken together, these ﬁndings indicate that the cyclic
portion of these peptides does not appear to have a signiﬁcant effect
on the activity while the N-terminal helix is largely responsible for
membrane interaction in the target membranes. One wonders, given
the high sequence conservation of these Rana box motifs, if these
peptides may have a dual biological role with this region of the
peptide displaying an as yet uncharacterized activity other than its
antimicrobial effect. Further information may begin to surface about
the exact molecular importance of the cyclic region with the
recombinant expression of this class of antimicrobial peptides [79]
which could allow for the incorporation of NMR active stable isotopes,
other than protons, into these molecules so that their membrane
interactions can be characterized in more detail.
One of the most interesting antimicrobial peptide structures
published to date is that of distinctin, a heterodimeric antimicrobial
peptide produced by the skin glands of Phyllomedusa distincta [81].
Distinctin is unique frommost other antimicrobial peptides in that it is
composed of two separate polypeptide chains that are joined by a
disulphide bond. Distinctin displays broad spectrum antimicrobial
activity against both Gram-positive and Gram-negative bacteria at
concentrations similar to conventional antibiotics. Secondary struc-
ture prediction of distinctin indicated the presence of signiﬁcant
helical structure and circular dichroism revealed increasing helical
content in the presence of TFE [81]. Both of these observations
suggested that the peptide may adopt a helical conformation in the
Table 3
Summary of the solution NMR conditions and the structural classes of the AAMP
structures examined in this review.
Peptide NMR conditions Structural class Ref
Magainin 2 TFE, SDS, DPC H [15,16]
PGLa DPC,SDS H [20]
Caerin 1.1 TFE, DPC H [25,26]
Caerin 1.4 TFE, DPC H [26]
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antimicrobial peptides. However, once the solution structure of
distinctin was published, it revealed a unique structural motif for an
antimicrobial peptide and also required a new hypothesis for the
mechanism of antimicrobial activity.
The detailed 3D solution structure of distinctin could be deter-
mined in a relatively easy fashion as the peptide was simply dissolvedCaerin 4.1 TFE H [33]
Citropin 1.1 TFE H [34]
Uperin 3.6 TFE H [35]
Hylaseptin P1 TFE H [36]
Frenatin 1 TFE H [37]
Aurein 1.2 TFE, SDS H [43,44]
Aurein 2.2 and 2.3 TFE H [7]
Dermaseptin B2 TFE, SDS H [50]
Dermaseptin S9 TFE H [51]
Dermaseptin S3 TFE U [52]
Temporin A TFE, SDS, DPC H [56,57]
Temporin L SDS, DPC H [57]
Buforin II TFE H [63]
Ranalexin TFE, DPC R [73]
Gaegurin 4 TFE, SDS, MeOH R [9,74,75]
Ranateurin-2CSa TFE R [77]
Nigrocin TFE R [8]
Distinctin Water U [82]
The structural classes are: H— Helical, R— Rana box peptide, and U — unique structure.
Fig. 5. Solution structure of distinctin showing the unique heterodimer structure (A and
B). (PDB ID 1XKM) A closer look at one of the A–B chains shows the hydrophobic
residues that are found at the dimer interface between the two peptides (Green
residues). The outer surface of the heterodimer consists primarily of hydrophilic and
charged residues colored in blue and red for positive and negative residues respectively.
C shows the top down view of one of the A–B chains in the top panel and the lower
panel is the same except viewed from the opposite face.in a 90%:10% mixture of H2O:D2O and then distance restraints were
taken from NMR NOESY spectra for the structure calculations.
Interestingly, distinctin formed a parallel (A–B)2 homodimer in
aqueous solution with the hydrophobic amino acids buried in the
center of the four helices from each of the polypeptide chains and the
polar and charged residues remaining exposed to the surrounding
solvent [82] (Fig. 5). This peculiar structure affords distinctin
increased protection against protease degradation [82], a problem
that plagues many linear antimicrobial peptides. Additionally, syn-
thetic analogs of distinctin made up of single peptide chains or
homodimerized peptides were proteolytically degraded, further
demonstrating that the tetrameric structure of distinctin is required
to resist the action of proteases [83]. Interestingly, the unique
structure of distinctin does not stop it from inducing pores in
syntheticmembranes, especially in the presence of negatively charged
lipids. 31P NMR and MD simulations suggest that peptide lined pores
are possibly involved in the antimicrobial activity of distinctin [83] but
the exact molecular arrangement of distinctin in bacterial membranes
is currently unknown. Be that as it may, these observations are in
agreement with the original hypothesis that it would require a large
structural rearrangement from the aqueous heterodimer structure of
distinctin to the active conformation that leads to bacterial cell death
[82]. A summary of the NMR solution structures of amphibian
antimicrobial peptides presented in this review is shown in Table 3.
3. Antimicrobial peptide synergy
As part of the innate immune system, antimicrobial peptides have
evolved over a long period of time to display activities against a variety
of bacterial species. Most of the research into antimicrobial peptides
has focused on purifying and characterizing these peptides, producing
the analogous synthetic peptides and examining their biochemical
and biophysical characteristics to elucidate a mechanism of action.
Additionally, substitutions can be made in synthetic antimicrobial
peptides to determine which residues are essential for the anti-
microbial activity and what alterations could potentially yield
peptides with enhanced bactericidal properties [84]. Long considered
a potential alternative to conventional antibiotics there are numerous
obstacles to the commercialization of antimicrobial peptides. These
include their high cost of chemical synthesis, a low stability in vivo and
unknown pharmacological properties [85]. Indeed, non-speciﬁc
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destabilization often require multimerization and a high number of
peptide molecules per bacterial cell. This requirement likely precludes
low concentrations of peptides from being antimicrobially active [86].
Thus, the high concentration of peptide required for activity further
compounds the problems associated with high production costs and
unknown effects on patients.
A new concept that is now emerging in antimicrobial peptide
research is the notion of synergy between antimicrobial peptides and
conventional antibiotics. The aim of this research is to take advantage
of the non-speciﬁc mechanism of an antimicrobial peptide and
augment this with the speciﬁc mechanism of a conventional
antibiotic. This strategy has had some successes already, for example
synergy between aurein 1.2 and two antibiotics, clarithromycin and
minocycline, was observed against nosocomial Gram-positive cocci
[87]. Also treatment of MRSA infections using a combination of
lysostaphin, an endopeptidase speciﬁc for the peptidoglycan of
staphylococci, and the frog antimicrobial peptide ranalexin has been
observed [88]. Other synergistic effects have been observed for
antimicrobial peptides in the presence of ﬂuoroquinolones [89],
beta-lactams [90], and vancomycin [91].
Synergy among antimicrobial peptides is another avenue of
research that is gaining in importance as it could potentially lower
the concentrations of peptides required for antimicrobial activity,
thereby lowering production costs and reducing the chances of host
toxicity. Synergy among antimicrobial peptides is an intuitive concept
if we consider that they are often produced naturally in conjunction
with a bevy of other peptides. A single cow is known to produce at
least 38 antimicrobial peptides which differ signiﬁcantly in their
amino acid sequences and respective structures [92]. A peptide/
protein extract of human colon mucosa displayed activity against
Gram-positive and Gram-negative bacteria and isolation and puriﬁca-
tion of these peptides revealed a complex mixture of antimicrobial
peptides including ubiquicidin, LL-37, HBD1-3 and HNP1, among
others [93]. In insects, antimicrobial peptides make up a signiﬁcant
portion of the innate immune response [94]. In particular, the immune
system of Drosophila has been extensively studied and up to 20
antimicrobial peptides have already been identiﬁed including droso-
mycin, unique to Drosophila, and defensins and cecropins, which are
found in other insect species as well [95]. Frog skin has also proven to
be a rich source of antimicrobial peptides and studies reporting on the
isolation and puriﬁcation of novel antimicrobial peptides from frog
skin are still common in the literature, even today [96–99].
One possible explanation for the apparent degeneracy of the
antimicrobial peptide response is that peptides may have unique
activities targeting distinct bacterial species and hence a larger
number of peptides ensures more complete protection against a
variety of pathogens [100]. Alternatively, if these peptides are able to
act synergistically on bacterial cells and kill pathogens at a lower
concentration then they do not need to be biosynthetically generated
in large quantities. Examples of this phenomenon can be found across
the animal kingdom and in all organisms that produce antimicrobial
peptides. Synergy between antimicrobial peptides was ﬁrst observed
in the dermaseptin family isolated from the Phyllomedusa genus of
frogs [101]. While all ﬁve dermaseptins displayed similar antifungal
activities, the activity against Gram-positive and Gram-negative
bacteria differed markedly as did the hemolytic activity in spite of
the high sequence similarity between these peptides. When used in
combination, a large 100-fold increase in activity was observed in
some cases showing that the combined action was better than the
sum of the individual peptides [101]. The short temporin peptides
also display synergism against Gram-negative bacteria. Temporin A, B
and L are all found in the skin of Rana temporaria, and all three are
active against Gram-positive bacteria but temporin A and B are
relatively ineffective against Gram-negative bacteria while temporin L
remains active. Interestingly, when Temporin A and B are mixed withtemporin L, a marked synergism is observed. The mechanism
underlying this synergy has been attributed to temporin L preventing
the oligomerization of temporin A and B in the presence of the outer
membrane endotoxin, LPS. This in turn allows temporin A and B to
translocate to the inner membrane where they are able to exert their
antimicrobial effect [59].
Synergistic relationships are not limited to antimicrobial pep-
tides from similar structural classes or even from the same species.
An interesting study published in 2001 looked at synergy among
four mammalian antimicrobial peptides, all with distinct structural
characteristics [100]. The authors examined the porcine β-hairpin
peptide protegrin-1, the human α-helical peptide LL-37, the loop
structured bovine peptide bactenecin, and bovine indolicidin which
is known to have a two turn structure. In general, most of the
peptide combinations displayed synergy against P.aeruginosa, E. coli
and E. faecalis [100].
One of the more extensively studied synergistic relationships
between antimicrobial peptides is the combined action of the frog
peptides magainin 2 and PGLa. Both peptides are secreted by the
epithelial cells of the African clawed frog, X. laevis [14,102] and
individually they possess broad spectrum antimicrobial activity
against a variety of bacterial species. Magainin on its own forms an
amphipathic helix in the presence of lipid bilayers and the helical
axis lies parallel to the surface of the bilayer [18,103]. PGLa also forms
an α-helix in the presence of negatively charged phospholipids [104]
and once again the helix axis lies parallel to the bilayer surface [20].
Magainin 2 induces lipid ﬂip-ﬂop of phospholipids in model
membranes which is attributed to the redistribution of peptide on
each side of the bilayer through the transient formation of
transmembrane toroidal pores [105,106]. Interestingly, the solution
structure of an equipotent magainin 2 analog, with the mutations
F5Y and F16W, bound to DLPC-d64 vesicles revealed a dimeric
structure [13] and the synthetic magainin peptide, MSI-78, was also
found to form a dimer in the presence of DPC micelles [22]. These
results, taken together with CD and ﬂuorescence studies on a
covalently linked dimeric version of the F5Y, F16W magainin 2
peptide [107], suggest that dimerization and cooperation among
magainin peptides could be an important step in the formation of
pores and the associated disruption of bacterial membranes. The
mechanism of membrane destabilization by PGLa has not been as
extensively studied. However, the presence of PGLa is known to
induce greater membrane permeability in negatively charges lipo-
somes [108] and DSC studies have demonstrated that PGLa
preferentially interacts with negatively charged phospholipids
[104]. Indeed, when tested with live E. coli cells, PGLa induced a
decrease in the surface stiffness of the bacterial membrane
eventually leading to the formation of micelles derived from the
outer membrane and ﬁnally complete cell rupture [109].
Interestingly, in combination magainin 2 and PGLa display marked
synergism in their antimicrobial activities and in their membrane
destabilizing properties as well [110,111]. Signiﬁcant work has been
done to elucidate the molecular mechanism behind this observed
synergy using a variety of biophysical techniques. Fluorescence results
indicated that these two peptides can form a 1:1 complex in the
presence of membrane mimetics and this heterosupramolecular
complex requires precise molecular recognition as magainin variants
mixed with PGLa were unable to release calcein dye from vesicles as
effectively as the parent magainin 2 peptide [112]. It is also interesting
that magainin–PGLa mixtures caused peptide translocation and lipid
ﬂip-ﬂop suggesting that the mechanism of membrane disruption
involves pore formation and is similar to that of the individual
peptides [112]. A parallel orientation of the two helices in the
heterodimer was suggested by a disulphide cross-linking study and its
formation was determined to be lipid dependent as disulphide linked
heterodimers preferentially formed in the presence of vesicles but not
in TFE/buffer or in buffer alone [113].
Fig. 6. Primary structure of the MG2–PGLa hybrid peptide (A). Note that both peptides
have two extra Gly and one Cys residue attached at their C-terminal end. The latter
allows cross-linking of the two peptides. Figure adapted from [132]. Circular dichroism
spectra of the MG2–PGLa hybrid peptide in the presence of (B) DPC and (C) SDS
micelles at various pH. CD data was acquired with a Jasco J-715 CD spectrophotometer
using a 1 mm path length cylindrical cuvette, with a 0.2 nm step resolution and a 1 nm
bandwidth. The scan rate was 50 nm/minute with a 2 second response time and the
spectrawere averaged over 8 scans. Spectrawere collected for samples of 30 μMpeptide
at pH 4.2, 7 and 9.0 for SDS and pH 3.9, 7.0 and 9.0 for DPC at 25 °C. For each type of
micelle, a background blank of micelle alone was acquired.
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Examining synergistic relationships between peptides is unfortu-
nately not a trivial task in antimicrobial peptide research because a
given peptide is present as the free peptide as well as an ordered
multipeptide complex. Consequently, any biophysical measurement
will observe the effects of both the synergistic interactions and the
individual peptide components. An alternative approach involves
producing hybrid peptides by combining the functional sequences
from separate antimicrobial peptides with the goal of generating
novel molecules with enhanced activity. Typically, peptide segments
with known antimicrobial activity are linked together in one
polypeptide chain. For example, a chimeric peptide composed of
RNA III-inhibiting peptide (RIP) and a dermaseptin derivative was
found to completely eradicate staphylococcal infections in a more
than additive fashion [114]. RIP disrupts quorum-sensing mechan-
isms in S. aureus by inhibiting the phosphorylation of TRAP (target of
RNAIII-activating protein) [115] which leads to the inhibition of
bioﬁlm formation [116], and toxin production [117] and ultimately
decreases the pathogenicity of the bacteria. Dermaseptins, as
described earlier, are antimicrobial peptides found in frog skin
[49,118] and the 13-mer derivative used in this study maintains the
large-spectrum antimicrobial activity in cultures and animal models
[119]. The increased activity of the chimeric peptide is attributed to
the unique mechanisms of each of the peptide components acting
simultaneously on the bacteria [114].
Another interesting example involves a hybrid peptide composed
of sequences derived from the insect antimicrobial peptide cecropin
and the cytotoxic bee venom peptide, melittin. Cecropin A was
originally isolated from the giant silk moth and has been shown to
have antibacterial activity against Gram-positive and Gram-negative
bacteria [120]. Melittin is the principal toxin found in bee venom that
displays signiﬁcant hemolytic activity against red blood cells [121].
Several studies of hybrid peptides involving portions of cecropin A and
melittin have been reported with enhanced antibacterial activity
while decreasing the high hemolytic activity associated with melittin
itself [122–125]. NMR solution structures of the hybrid peptides reveal
mostly helical conformations separated by ﬂexible hinge regions
[126,127] similar to the solution structures that have been reported for
cecropins [128,129] and melittin [130,131]. In the case of the hybrid
peptides, it appears that those regions responsible for antibacterial
activity have been preserved while removing those helical segments
that induce hemolysis.
5. Solution structure of the MG2–PGLa hybrid peptide
The synergy observed between magainin 2 and PGLa as well as
the earlier peptide cross-linking study which established a parallel
orientation between the two helical peptides inspired the design of a
unique hybrid peptide where both peptides are linked together
through a disulphide bond and several Gly residues [132] (Fig. 6). In
this hybrid peptide, the F5W-magainin 2 (MG2) mutant of magainin
2 is used instead of the native magainin sequence. The MG2 peptide
was originally designed to examine interactions between magainin 2
and membranes by ﬂuorescence spectroscopy. It has been shown to
be equipotent to magainin 2 [103]. Such Trp residue substitutions are
quite often used as they also allow for accurate peptide concentra-
tion determinations by UV-spectroscopy. The goal of this study was
to elucidate the molecular mechanism of synergy between MG2 and
PGLa while removing unassociated peptides from the analysis. The
hybrid peptide, MG2–PGLa, displayed even stronger membrane
leakage from negatively charged vesicles properties compared to a
mixture of magainin 2 and PGLa [113] and has been shown to be
signiﬁcantly more active against E. coli and S. epidermis [132]. Trp
ﬂuorescence measurements also indicated that the hybrid peptide
inserted into the membrane at a similar depth compared to theindividual peptide components [132]. Thus the MG2–PGLa peptide
appears to be a suitable construct for examining the synergistic
relationship between these two antimicrobial peptides. Curiously,
the hybrid peptide also displayed signiﬁcantly higher hemolytic
activity than the 1:1 mixture of the peptides indicating that the
synthetic heterodimer somehow enhances the interaction with
eukaryotic membranes [132].
Several solid state NMR studies of MG2–PGLa have revealed some
interesting results about the interactions betweenmagainin, PGLa and
phospholipid bilayers. A solid-state 2H-NMR study revealed that PGLa
adopts a transmembrane orientation when mixed at an equimolar
concentration of magainin 2 [133]. PGLa had a tilt angle of 158° with
respect to the bilayer normal when magainin 2 was present which is
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in DMPC bilayers [134]. These results suggest that normally PGLa is
surface oriented on bacterial membranes and then, at higher
concentrations, it dips into the core of the membrane. However,
with magainin 2 present, PGLa can adopt a transmembrane orienta-
tion at a lower concentration leading to the formation of pores. Such a
mechanism offers a direct explanation for the synergistic relationship
between these two peptides.
To further examine themolecular interactions betweenmagainin 2
and PGLa, we have examined the three-dimensional solution structure
of the MG2–PGLa hybrid peptide in the presence of SDS and DPC
micelles. In the following we will outline the outcome of the NMR
structure determination and we will shed some light on the
intermolecular interactions that may be essential for the synergistic
activity between magainin2 and PGLa.
5.1. Structure determination
Before we initiated the NMR study we studied the hybrid by CD
spectroscopy at a variety of pH values. Fig. 6(B and C) shows the CD
spectra obtained for the peptide in the presence of DPC and SDS
micelles at acidic, neutral and basic pH. Both sets of spectra display the
characteristic shape attributed to helical peptides with a large positive
ellipticity at 195 nm, and negative minima at 208 and 222 nm. The
spectra also resemble the spectra obtained from the 1:1 combination
of magainin and PGLa in the presence of small unilamellar vesicles
[112]. In the presence of DPC micelles there is only a small variation
between spectra for the three pH values occurring at 195 and 208 nm.
In the presence of SDS micelles there is a slightly larger increase inFig. 7. Fingerprint region of the 2D 1H-NOESY spectra of the MG2–PGLa hybrid peptide with S
themagainin2 portion (m) or PGLa portion (p) of the hybrid peptide. Brieﬂy, twoNMR sampl
One sample was adjusted to pH 4.3 and data was acquired prior to adding 9.6 mg SDS-d25 an
was adjusted to 4.3. After data collection on the SDS sample, NaCl was added to achieve 50helicity in the progression from basic to acidic solution. Since the
background spectra for the micelles alone showed very little
absorbance (data not shown) this change most likely reﬂects the
effect that pH has on the degree of peptide protonation and the
interactionwith the sulphate groups at the interface of themicelle and
aqueous solvent. Qualitatively, the peptide retains helical character
over the entire pH range from∼4 to∼9 in the presence of SDS and DPC
micelles. Therefore it would be expected that the conformations of the
disulphide cross-linked peptides [113] are similar to the conforma-
tions of the individual peptides determined earlier, and that structure
determination can be pursued at a lower pH, which is advantageous
for NMR spectroscopy because of reduced hydrogen exchange.
All NMR data collection and analysis strategies used to determine
the solution structure of the MG2–PGLa hybrid peptide are similar to
the strategies used by our group to examine the solution structures of
other antimicrobial peptides bound to detergent micelles [135–137].
The 2D NOESY NMR spectra of the peptide obtained in aqueous
solution did not indicate the presence of secondary structure.
However, in the presence of either DPC or SDS micelles, the increase
in number and the distribution of new correlations indicated that
signiﬁcant secondary structure had been induced. For the peptide in
both types of micelles there was spectral overlap even at 700 MHz
(Fig. 7). This proved especially problematic when adjacent or
neighboring residues have either amide or alpha protons overlapping
as this creates a difﬁculty for assignment of the interactions necessary
for deﬁning secondary structure. The degeneracy of chemical shifts
also leads to multiple assignments for some correlations. As a result,
important interactions for some of the residues required for deﬁning
secondary structure (dNN (i,i+2),dαN (i,i+3) and dαN (i,i+4))DSmicelles. The annotations indicate the identity of the amide chemical shifts for either
es were prepared by dissolving 2–3mg of the hybrid peptide in 0.5 ml of 90:10 H2O:D2O.
d adjusting the pH to 4.2. 22.2 mg of DPC-d38was added to the other sample and the pH
mM salt concentration.
Fig. 8. Backbone overlays of the 20 lowest energy structures for the individual peptide
components of MG2–PGLa hybrid peptide. A and B show the MG2 and PGLa portions
respectively of the hybrid peptide in DPC. C and D are MG2 and PGLa regions of the
hybrid peptide in the presence of SDS. The MG2 residues are ﬁt across residues 7–21
while the PGLa peptide is superimposed across residues 6–14.
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the magainin portion Leu6–His7, Ser8–Lys10, Glu19–Ile20, and the
PGLa portion Ala20–Leu21 in the peptide–SDS micelle. The 2D NOESY
spectrum obtained from the peptide with DPC micelles had amide
proton chemical shifts over a much broader range (7.6–9.4 ppm, data
not shown). However, there were regions of high overlap (e.g.
magainin portion Leu6, His7, Phe12, Val17, Met21 with Gly 24 and
PGLa portion Ser4 and Cys24 all proximal to 8.25 ppm).
In both types of micelles tested (SDS and DPC), the magainin
peptide showsmany characteristic helix-forming interactions over the
entire length of the peptide. However, the PGLa peptide lacks
interactions for the N-terminal end of the peptide. The chemical
shift index [138] also gives a perspective independent of assigned
correlations for evaluating helicity (see Supplementary Figure). For
both micelle systems the index reﬂects the lack of complete helical
characteristics as some of the residues do not have a chemical shift
that is indicative of deﬁnite helical nature. This does not imply that the
peptide is necessarily random coil in these sections, but may have a
more open coil orientation than is required for a true helix [138].
Although the magainin portion of the peptide with either type of
micelle does not have as many interactions as previously determined
from interactions with phospholipid vesicles [13], it would seem to
retain 60–90% helicity as is common for the magainin family of
peptides under similar experimental conditions [139].
The NOESY spectrum for the peptide with DPC micelles not only
produced intrastrand interactions but also indicated 9 additional
inter-strand interactions between the magainin and PGLa peptides.
These interactions were between side chain protons from magainin
Phe16-Ile20 to PGLa Ile9-Lys15 and one to Leu21. Most of these
correlations are easy to identify as they appear in the upﬁeld aliphatic
regions of the 2D NOESY spectrum where there is no spectral
crowding. There were no other inter-strand interactions observed
from residues closer to the N-terminal ends of the peptide portions.
The same trend was not observed between the two strands of the
peptide in the presence of SDS micelles. To ensure that the lack of
interactions was not produced bymolecular motions on the NMR time
scale, the peptide was run at 500MHz at both 25 °C and 37 °C, in the
presence of 50 mM NaCl and at a different peptide concentration.
Since the inter-strand interactions observed from the neutral PC lipid
micelle occurred mostly between side chains of hydrophobic residues,
the signiﬁcance of hydrophobic interactions in the absence of strong
electrostatic peptide–lipid forces may be dominating [140]. Conver-
sely, in the presence of the negatively charged SDS micelles, a variety
of possible conformations permits maximum dispersion of peptide
positive charge over the exterior of the micelle. In the more charged
environment, hydrophobicity seems to play a secondary role. Thus
overall, hydrophobicity may play a signiﬁcant role in association of
magainin and PGLa peptides during their dimerization.
5.2. Structural analysis
For the peptide in either type of micelle there was an average of
greater than 17 constraints per residue of both intra- and inter-residue
interactions. However, these interactions were not evenly distributed.
Furthermore, the lack of regular secondary structure throughout the
entire strand of the magainin portion of the hybrid peptide is reﬂected
by the overlap of the 20 lowest energy structures with the DPC
micelles having RMSD of 0.76 Å for the backbone atoms of His7 to
Met21 of magainin (Fig. 8). In all 20 structures, the magainin portion
consistently showed helicity from Lys5–Gly11 and from Ala17 to
Ala20. Recall that magainin on its own adopts a helical conformation
in micelles (Fig. 1) with the helix stretching across residues 2–22 [16].
For the PGLa portion of the hybrid peptide in DPC micelles, once again
we see that the peptide is relatively unstructured at the N and C
terminus however a well deﬁned helical conformation emerges from
Ala6 to Ala14 possessing a backbone RMSD of 0.63 Å (Fig. 8) which issmaller than that observed for the free PGLa peptide bound tomicelles
where the helix stretches from Ala6 to Leu21 [20].
In the presence of SDS micelles, the peptide structures generated
have a larger RMSD value for the same regions of the hybrid peptide.
While the magainin portion adopts a similar conformation compared
to the DPC bound structure, it has a backbone RMSD of 1.40 Å between
His7 andMet21. It is obvious that this is not as well deﬁned as the DPC
bound form (Fig. 8). Interestingly, the PGLa portion of the hybrid
peptide adopts a very similar structure when interacting with SDS
micelles compared to the DPC bound conformation. With a backbone
RMSD of 0.71 Å across residues 6–14 (Fig. 8), it is well deﬁned similar
to this part of the hybrid peptide bound to DPC micelles. The MG2–
PGLa peptide consistently appeared helical from magainin residues
Phe12–Glu19 and PGLa Ile13–Val16 with some helicity observed in
magainin residues Leu6–Ala9 and Glu19–Asn22 and PGLa residues
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conformations can be seen as a table in Supplementary material.
Representative structures of the hybrid peptide in DPC and SDS are
shown in Figs. 9 and 10. Fig. 9(A and B) show two different
perspectives of the hybrid peptide with DPC micelles. Also indicated
are the residues involved in inter-strand interactions as indicated from
the 2D NOESY spectrum. In Fig. 9C and D, the surface chargeFig. 10. Ribbon diagram of the lowest energy structure of the MG2–PGLa hybrid peptide
bound to SDS micelles.
Fig. 9. Ribbon diagram of a representative structure of the MG2–PGLa hybrid peptide
bound to DPC micelles. Residues with observable interstrand nOes are indicated with
dashed lines and the disulphide bond holding the two peptides together is shown in
gold (A). When viewed from the side, the orientation of the two helices with respect to
each other is evident (B). Surface charge distribution reveals the amphipathic nature of
each of the PGLa and themaganin 2 components of the peptide. In C, the PGLa peptide is
closest to the reader while the opposite face is shown in D with magainin 2 oriented
closest to the reader. Uncharged regions of the peptide appear white while cationic and
anionic regions are colored blue and red respectively.distribution shows two hydrophobic surfaces on the outer portions
of the peptidewith the hydrophilic surfaces appearing to interact with
each other in the center of the molecule. A representative structure of
MG2–PGLa bound to SDS micelles can be seen in Fig. 10. In this case, it
was difﬁcult to observe interstrand nOes but the helical nature of the
two peptide components is evident. Since amphipathic character is
inherent in the magainin and PGLa peptides in the presence of lipids
[16,20,139], the lowest energy conformations for the peptide with SDS
may be further constrained if a suitable method is found to limit
electrostatic charge of the peptide to one face of the molecule. This
additional constraint would restrict motions about the junction of the
magainin and PGLa portions of the peptide to create a true
amphipathic conformation. It should be noted that cross-linking
magainin and PGLa in this fashion has been shown to strengthen the
hemolytic activity of the peptide and increase the membrane
destabilizing effects on zwitterionic membranes [132]. This could be
related to the fact that the MG2–PGLa peptide appears to form
intermolecular contacts more readily between the two helices in DPC
micelles, which resemble zwitterionic eukaryotic membranes, com-
pared to SDS micelles, which are a better mimic of negatively charged
bacterial membranes.
The solutions structures of the hybrid peptide bound to SDS and
DPC micelles presented here have some interesting properties that
hint at the importance of dimer formation but these structures also
highlight some of the limitations of using conventional non-isotope
labeling proton and nOe-based NMR techniques to examine synergis-
tic relationships between antimicrobial peptides. While each peptide
component of the hybrid peptide adopted a mostly α-helical
conformation, neither of the calculated structures resulted in two
helices that oriented themselves in the same manner with respect to
each other, in spite of the presence of several interhelix nOes between
the two peptides. Relative helix orientation in isotope labeled proteins
can be extremely well deﬁned by residual dipolar couplings [141],
however since the two peptides are not isotope-labeled, this
experiment is not feasible for the hybrid peptide. It is possible that
either the magainin half or the PGLa portion bind to a single micelle
and adopt a conformation similar to that seen for the individual
peptides in the presence of micelles [19,20]. The diameter of the
micelle may simply be too small to accommodate the dimeric
structure that has been proposed for the hybrid peptide.
An alternate explanation could be that the helical strands of the
hybrid peptide do associate with each other but they do so
dynamically, alternating between associated helices and their indivi-
dual conformations. This scenario would generate the weak nOes
observed between the two helices in the DPC bound structure and
would also suggest that the negatively charged SDS micelles do not
favor the realignment of the two helices. These results suggest that the
disulphide bond that links themagainin and PGLa peptides together in
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the orientation of the two helices with respect to each other but
instead it simply keeps the two peptides in close proximity to each
other, making inter-helix interactions between the two helices more
likely. Since we know that the synergistic activity of magainin 2 and
PGLa is dependent on their interactions in the membrane [112,133]
then it stands to reason that keeping these two peptides close
together would favor the formation of the active heterodimer
structure in the presence of a bacterial membrane. It would be
interesting to examine the solution structure of MG2–PGLa in the
presence of a phospholipid bilayer but these techniques are more
challenging because of the size of the vesicle species which increases
the correlation time and leads to the broadening of NMR signals. Some
success has been achieved using phospholipid vesicles [13] and
bicelles [142] but examples of this type of analysis, especially for
studying synergistic relationships between antimicrobial peptides, are
limited at the moment.6. Conclusions
AAMPs are common throughout nature and novel sequences are
continuously being reported. In this reviewwe have discussed that the
majority of these peptides are membrane active and adopt a distinct
three dimensional helical structure in the presence of membranes,
detergent micelles and membrane mimetic solvents. Many of these
sequences and structures are conserved among several frog species
and most structure function analyses suggest similar mechanisms of
action. However, some peptides fold in the presence of membrane
mimicking solvents but are not membrane active or they adopt a
unique conformation which has implications for their mechanism of
antimicrobial activity. This demonstrates the need to examine the
solutions structure of each peptide individually and establish correla-
tions between the observed conformation and other biophysical and
biological data that relate to the mechanism of action. In this review
we have also highlighted some of the research that aims to examine
synergistic relationships among antimicrobial peptides. Structural
characterization of the synergistic relationship is important to
elucidate which residues are involved in the synergistic interaction.
We have also presented the ﬁrst solution structure of amagainin 2 and
PGLa hybrid peptide linked through a disulphide bond in the presence
of SDS and DPC micelles. While our results do not indicate the
formation of a stable heterodimeric conformation, evidence of partial
inter-helical contacts in the presence of zwitterionic detergent
micelles could be obtained. These results demonstrate both the
usefulness and limitation of solution state NMR structure determina-
tion but do emphasize that structural analysis of synergistic interac-
tions maywell become an important step towards the development of
new therapeutic practices and novel antimicrobial formulations
involving an array of antimicrobial peptides.Acknowledgements
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